Nyxoah S.A.

NASDAQ:NYXH

Medical - Instruments & Supplies

Healthcare
$0.86 +1.25%

+$0.02 today

Market cap
$87.89M
Beta
0.89
P/E (TTM)
-0.7
EPS (TTM)
-$1.99
52W Low $1.26High $8.59

Volume 0.17M

Average 0.22M

NYXH Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

Nyxoah S.A.NASDAQ: NYXH

Income Tax Expense · Q1 FY2026 · quarter ended Mar 2026

Income tax expense growth accelerates

Q1 FY2026 income tax expense of €450.59K rose 260.5% year over year, ahead of the -52.7% change in trailing-twelve-month income tax expense. Sequentially, it fell 49.7% from the prior quarter. Over 3 fiscal years it compounded at -4.8% a year.

Context

  • Income tax expense amounted to 10.1% of revenue in FY2025, down 52.0 pp from a year earlier.
  • Income tax expense increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +260.5% holds above the trailing-twelve-month pace of -52.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
€450.59K-49.7% QoQ
Last fiscal yearDec 2025
€1.01M-64.0% YoY
LTMMar 2026
€1.33M-52.7% YoY
Income Tax Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+260.5%——
1 year-64.0%——
3-year CAGR-4.8%——
5-year CAGR——
10-year CAGR——

Income Tax Expense history

EUR · from the income statement

Latest · FY2025
1.01M EUR
Year-over-year change
-64.0%
4-year CAGR
-23.7%

Income Tax Expense vs competitors

How NYXH compares with its peers on the latest reported figures

  • Peers report in different currencies, so income tax expense is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -52.7% is the lowest of 7, against a peer median of +81.9%.
  • Income tax expense amounts to 8.2% of revenue for NYXH, versus a peer median of 0.8%.
NYXH Competitors
Income Tax Expense for NYXH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
UTMDUtah Medical Products, Inc.LTM Mar 2026$2.58M USD-11.0%-12.3%6.9%
OSUROraSure Technologies, Inc.LTM Mar 2026$1.83M USD+34.1%+7.3%1.6%
NYXHNyxoah S.A.LTM Mar 2026€1.33M EUR-52.7%-4.8%8.2%
OABIOmniAb, Inc.LTM Mar 2026$913K USD+113.3%—3.2%
PREPrenetics Global LimitedLTM Mar 2026$47K USD+100.6%—0.0%
KRMDKORU Medical Systems, Inc.LTM Mar 2026$21.89K USD+656.7%—0.1%
IVVDInvivyd, Inc.LTM Mar 2026$0 USD——0.0%
TARAProtara Therapeutics, Inc.LTM Mar 2026$0 USD———
STIMNeuronetics, Inc.LTM Mar 2026$0 USD——0.0%
CATXPerspective Therapeutics, Inc.LTM Mar 2026-$793K USD+63.3%—128.3%
Peer median (excluding NYXH) —+81.9%-2.5%0.8%

Competitors are the stored peer set for NYXH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue852K3.08M4.35M4.52M10.02M
Cost of Revenue303K1.15M1.66M1.55M3.69M
Gross Profit549K1.93M2.69M2.97M6.33M
Gross Margin64.4%62.7%61.9%65.7%63.1%
Research & Development5.95M15.86M27.66M34.33M42.82M
Selling, General & Admin11.11M18.86M20.65M28.46M46.44M
Operating Expenses26.79M34.43M47.79M61.78M89.27M
Depreciation & Amortization1.66M1.93M2.36M764K4.48M
EBITDA(22.59M)(27.89M)(42.08M)(53.77M)(82.9M)
EBITDA Margin-2651.5%-904.2%-967.8%-1189.2%-827.4%
Operating Income(26.24M)(32.5M)(45.1M)(58.81M)(82.94M)
Operating Margin-3080.0%-1053.8%-1037.3%-1300.8%-827.8%
Interest Income1K372K2.57M2.5M1.83M
Interest Expense386K237K1.21M1.9M1.69M
Other Income / Expenses1.6M2.44M445K2.38M(6.13M)
Income Before Tax(24.64M)(30.06M)(44.66M)(56.43M)(89.08M)
Pre-Tax Margin-2891.9%-974.6%-1027.1%-1248.2%-889.0%
Income Tax Expense2.98M1.17M(1.45M)2.8M1.01M
Net Income(27.62M)(31.23M)(43.21M)(59.24M)(90.09M)
Net Margin-3241.7%-1012.5%-993.8%-1310.2%-899.1%
EPS (Basic)(1.16)(1.21)(1.55)(1.81)(2.37)
EPS (Diluted)(1.16)(1.21)(1.55)(1.81)(2.37)
Weighted Avg Shares23.79M25.82M27.97M32.74M38.11M
Weighted Avg Shares (Diluted)23.79M25.82M27.97M32.74M38.11M

Nyxoah S.A.

NASDAQ:NYXH

Intrinsic Alpha fair value

Locked

Current Price

$0.86

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.